通过乙化德克斯微粒控制释放聚 () 通过乙化德克斯微粒进行增强的疫苗辅助剂输送
Sophia A Ly1, Nicole Rose Lukesh2, Erik S Pena1
1Lampe Joint Department of Biomedical Engineering, NC State/UNC, Chapel Hill, NC, USA.
bioRxiv : the preprint server for biology
|August 8, 2025
概括
在乙化德克斯微粒中封装的多URNA显示出基于形态学的独特免疫反应. 光滑的微粒提升了T细胞的反应,而纹的微粒提升了B细胞的活动,有助于疫苗的开发.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 药物输送系统 药物输送系统
背景情况:
- 新型疫苗组件需要先进的输送系统来提高有效性.
- 聚U) RNA,一种类似收费受体 (TLR) 7/8的激动剂,刺激先天免疫系统,但容易降解和细胞吸收不良.
- 乙化德克斯 (Ace-DEX) 是一种pH值敏感的,可生物降解的聚合物,适用于封装敏感分子.
研究的目的:
- 调查微粒子形态学对基于多元 (U) RNA的疫苗疗效的影响.
- 为了比较由光滑与纹的多分子 (U) RNA装载的Ace-DEX微粒引起的免疫反应.
- 为了确定微粒表面特征如何影响特定的免疫细胞群.
主要方法:
- 通过喷雾干燥,聚氨酸RNA被封装成具有光滑或纹表面的Ace-DEX微粒 (MP).
- 试验室研究评估了暴露于不同MP的树突细胞 (DC) 的活力和细胞因子反应.
- 在体内研究中,小鼠接种了光滑或纹的聚氨酸与卵蛋白 (OVA) 结合的MPs,并在重新刺激时分析免疫细胞频率和细胞因子产生.
主要成果:
- 与纹的MP相比,光滑的多UMP显示出更高的树突细胞活力和细胞因子生产.
- 接种光滑多U) MPs + OVA的疫苗增强了IL-2和IFN-γ的产生,表明强大的T细胞激活.
- 纹多U) MPs + OVA显著增加了B细胞和生殖中心B细胞频率,表明了明显的B细胞中心免疫调节.
结论:
- 微粒体形态极大地影响了基于多元 (U) RNA的疫苗产生的免疫反应类型.
- 光滑的MP优先调节树突细胞和T细胞,而纹的MP则增强B细胞反应.
- 量身定制微粒表面特征为优化针对细胞免疫的疫苗设计提供了一种战略.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


